Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach

The Journal of Allergy and Clinical Immunology In Practice(2021)10.1016/j.jaip.2021.06.006Source: DataRank Database

The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach is a research paper published in The Journal of Allergy and Clinical Immunology In Practice (2021). On theSindex it has a DataRank of 0. It has been cited 210 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access210 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 7.95)OA: hybridTopics (46)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (63)

Elissa M. Abrams ORCID,Marcus Shaker,Derek K. Chu ORCID,David A. Khan ORCID,Cem Akin ORCID

Live enrichment

PubMed:34153517 PMC:PMC8248554 OpenAlex:https://openalex.org/W3175982156

National Institute of Allergy and Infectious Diseases

National Institutes of Health

Division of Intramural Research, National Institute of Allergy and Infectious Diseases

FWCI

7.95

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by-nc-sa

journalhttp://www.jaci-inpractice.org/article/S2213219821006711/pdf

publisherhttp://www.jaci-inpractice.org/article/S2213219821006711/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2213219821006711?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2213219821006711?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jaip.2021.06.006

Fields of Study

SARS-CoV-2 and COVID-19 ResearchAllergic Rhinitis and SensitizationInfection Control and VentilationHumansAnaphylaxisConsensusCOVID-19COVID-19 VaccinesGRADE ApproachRNA, ViralSARS-CoV-2Consensus Statements as Topic

MeSH Terms

GRADE ApproachCOVID-19SARS-CoV-2COVID-19 VaccinesAnaphylaxisConsensus Statements as TopicHumansRNA, ViralConsensus

Keywords

MedicineMeta-analysisCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakMEDLINERisk assessmentIntensive care medicineFamily medicineVirologyInternal medicineAllergyVaccinationGradepolyethylene glycolShared Decision MakingAllergic ReactionsPolysorbate 80anaphylaxisSkin TestingMrna VaccineAllergy SpecialistCovid-19Sars-cov-2Adenovirus-vector Vaccine

Sustainable Development Goals

SDG 0: Good health and well-being

The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach

FAIR Checklist

Authors (63)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)